Dr. Josh Salvi is a psychiatrist at the MGH Center for OCD and Related Disorders, an Associate Program Director of the MGH/McLean Psychiatry Residency Program, Director of the Physician Scientist Training Program (PSTP) in Psychiatry, and an Investigator at the MGH Translational Research Center. Dr. Salvi also teaches medical students in multiple capacities at Harvard Medical School. Dr. Salvi earned his Ph.D. in Neuroscience from The Rockefeller University in the Laboratory of Sensory Neuroscience with A. James Hudspeth. He graduated from Weill Cornell Medical College and has received various awards, including the Gold Humanism Honor Society’s Humanism in Medicine Award, the John Metcalf Polk Prize for academic achievement in medical school, the American Psychiatric Association’s Leadership Fellowship, the NIMH Outstanding Resident Award Program, the Broad Institute’s Pamela Sklar Fellowship for psychiatric research. He has a research interest in behavioral and genetic studies in OCD and is thrilled to continue clinical work in the same area.

Brynn Huguenel, PhD is a staff psychologist in the Center for OCD and Related Disorders (CORD) at Massachusetts General Hospital (MGH) and an Instructor in Psychology (Psychiatry) at Harvard Medical School (HMS). She is also a staff psychologist on MGH’s inpatient psychiatric unit (Blake 11) and in the Psychological Evaluation and Research Lab (PEaRL). Dr. Huguenel received her PhD in clinical psychology from Loyola University Chicago. She completed both her clinical internship and post-doctoral fellowship at MGH/HMS. She is a licensed clinical psychologist in the state of Massachusetts and specializes in cognitive-behavioral therapy for OCD and related disorders, as well as anxiety more broadly. Dr. Huguenel’s research aims to improve the accessibility of evidence-based mental health treatment through the development, implementation, and evaluation of intervention programs, particularly digital technologies.

Emily Bernstein, PhD is an Assistant Professor at Harvard Medical School (HMS) and a staff psychologist in the Center for OCD and Related Disorders (CORD) at Massachusetts General Hospital (MGH). Dr. Bernstein received her bachelor’s degree from Yale University and her PhD in clinical psychology from Harvard University. She completed her clinical internship at VA Boston Healthcare System and postdoctoral training at MGH/HMS and is a licensed psychologist in the state of Massachusetts. Dr. Bernstein’s research is focused on developing alternative and more scalable approaches for the prevention and treatment of OCD and related disorders, anxiety disorders, depression, and other emotional concerns. This includes exploring exercise and other lifestyle interventions and brief cognitive behavioral treatments, as well as leveraging digital tools to bring evidence-based therapy to more people. In this pursuit, she also aims to understand why psychological interventions work, and particularly transdiagnostic ones (or those targeting processes that cut across emotional disorders, like perseverative negative thinking), and to use these insights to increase the efficiency and impact of treatments. Dr. Bernstein was a 2022 recipient of the Anxiety and Depression Association of America (ADAA) Alies Muskin Career Development Leadership Program Award and member of the Career Development Institute for Psychiatry.

Adam Jaroszewski, Ph.D. is an Instructor at Harvard Medical School (HMS) and a Staff Psychologist in the Center for OCD and Related Disorders at Massachusetts General Hospital (MGH). He completed his doctorate in clinical psychology at Harvard University and clinical internship and postdoctoral fellowship a MGH/HMS. Dr. Jaroszewski is a licensed psychologist in the state of Massachusetts, whose clinical work focuses on the treatment of OCD and related disorders as well as anxiety and depression. His research focuses on examining the cognitive and affective factors that increase risk for the development and maintenance of self-injurious thoughts and behavior (SITB). He is particularly interested in using approaches from decision and affective science to understand why people decide to engage in SITB. He is also involved in developing scalable, smartphone delivered interventions for SITB and associated disorders (e.g., depression, BDD).